leisure time -WSS

leisure time

author：entertainment 2025-10-01 20:16:06 - browse：678

Photo illustration of the FDA US Food and Drug website. -- health policy coverage from STAT — Adobe

WASHINGTON — Food and Drug Administration officials hope to finish this year a massive overhaul of the way the agency inspects facilities that make drugs, medical devices, and food products, they said Friday.

The reorganization was spurred by the FDA’s mishandling of the infant formula crisis. The agency was slow to inspect a major infant formula plant despite a whistleblower complaint about deadly bacterial contamination at the facility. An investigation found that the delayed response was due in part to the agency’s organization. A nonprofit, nonpartisan advisory body reported in December it was not clear who is in charge of food oversight, and agency food safety staff are siloed among divisions that don’t communicate with each other.

Although the food center has been the focus of attention in the reorganization, it will affect a huge swath of the agency. The reorganization is expected to impact about 8,000 FDA employees, according to Michael Rogers, FDA associate commissioner for regulatory affairs. The Office of Regulatory Affairs, which will be called the Office of Inspections and Investigations under the proposed reorganization, will go from having about 5,100 full-time employees to 3,586 employees.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Color Health wants to make cancer screenings convenient

WSS

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

Merck, Johnson & Johnson CEOs will testify on high drug prices

STAT Madness 2024: Meet the contenders

Humana’s losses in Medicare Advantage tank its stock

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

leisure time

leisure time

explore

After affirmative action ruling, medical educators look to 'holistic review'

10 reasons why health care startups fail

Trump demands the U.S. pay no more for drugs than other countries … again

Medicare Advantage isn’t working — for anyone

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Cholera vaccine supplies dangerously low, outbreaks surging

DIEP, the 'gold standard' of breast reconstruction, is under threat

Merck, Johnson & Johnson CEOs will testify on high drug prices

Cancer drug shortages should be causing more outrage

Investment in vaccine development is lagging, report finds

explore

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

White House pharmacy plagued with problems, investigation finds

Medicare Advantage insurers face 0.2% cut to 2025 payments

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

Doctor of U.S. President Joe Biden says he is fit for duty

Pancreatic cancer early detection could be helped by AI

Wikipedia

hotspot

Wikipedia

explore